Metal Complexes and Medicine: A Successful Combination.
1University of Zurich Department of Chemistry Winterthurerstrasse 190 CH-8057 Zurich, Switzerland. gilles.gasser@chem.uzh.ch.
Chimia
|May 10, 2017
Summary
Metal complexes show promise in combating schistosomiasis, a parasitic disease. Our research highlights recent achievements in developing these compounds for medicinal chemistry applications against this neglected tropical disease.
Area of Science:
- Medicinal Chemistry
- Parasitology
- Coordination Chemistry
Background:
- Schistosomiasis remains a significant global health burden, particularly in tropical regions.
- Current treatments for schistosomiasis have limitations, necessitating the development of novel therapeutic strategies.
- Metal complexes offer a versatile platform for drug discovery due to their diverse coordination environments and potential biological activities.
Purpose of the Study:
- To review recent advancements in the application of metal complexes for the treatment of schistosomiasis.
- To highlight the group's contributions to the field of metal-based therapeutics for parasitic diseases.
- To explore the potential of novel metal compounds in combating schistosomiasis.
Main Methods:
- Synthesis and characterization of various metal complexes.
- In vitro and in vivo screening of metal complexes against schistosome parasites.
- Structure-activity relationship studies to optimize therapeutic efficacy.
Main Results:
- Several metal complexes demonstrated significant activity against Schistosoma parasites.
- Identification of specific metal ions and ligand scaffolds that enhance antiparasitic effects.
- Preliminary data suggests favorable toxicity profiles for promising drug candidates.
Conclusions:
- Metal complexes represent a promising avenue for the development of new schistosomiasis treatments.
- Continued research in metal-based medicinal chemistry is crucial for addressing neglected tropical diseases.
- Further investigation is warranted to translate these findings into clinical applications.
More Related Videos
Related Concept Videos
Metal-Ligand Bonds
24.9K
The hemoglobin in the blood, the chlorophyll in green plants, vitamin B-12, and the catalyst used in the manufacture of polyethylene all contain coordination compounds. Ions of the metals, especially the transition metals, are likely to form complexes.
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
24.9K
Complexation Equilibria: The Chelate Effect
1.4K
In complexation reactions, metal atoms or cations interact with ligands to form donor-acceptor adducts called metal complexes. Ligands that bind through one donor site are monodentate, ligands with two donor sites are bidentate, and those with more than two donor sites are polydentate ligands. For example, ethylene diamine is a bidentate ligand that binds through two nitrogen donor atoms, forming a five-membered ring. EDTA is a polydentate ligand that binds through four oxygen and two nitrogen...
1.4K
Complexometric Titration: Ligands
2.4K
Different monodentate and polydentate ligands are used as complexing agents in complexometric titration reactions. The formation of complexes by mono- and bidentate ligands involves two or more intermediate steps, limiting their use as complexing agents. In comparison, polydentate ligands can form complexes with metal ions in a single-step process, facilitating sharper end points. This means polydentate ligands, such as amino carboxylic acid derivatives, are most commonly employed in...
2.4K
Complexation Equilibria: Factors Influencing Stability of Complexes
892
In complexation reactions, metal cations are the electron pair acceptors, and the ligands are the electron pair donors. The stability of the metal complexes depends primarily on the complexing ability of the central metal ion and the nature of the ligands. Generally, the complexing ability of the metal ion depends on the size and charge of the ion. As the metal ion size increases, the stability of the metal complexes decreases, provided that the valency of the metal ion and the ligands remain...
892
EDTA: Chemistry and Properties
3.6K
Polydentate ligands are most widely used in complexometric titrations because they form more stable complexes with the metal ions than mono- or bidentate ligands due to the chelate effect. Examples of polydentate ligands are ethylenediaminetetraacetic acid (EDTA), crown ethers, and cryptands. The most important feature of optimal polydentate ligands is the ability to form 1:1 complexes in a single-step process. Amino carboxylic acid derivatives are frequently used as complexing agents. EDTA is...
3.6K
Extraction: Advanced Methods
1.2K
Metal ions can be separated from one another by complexation with organic ligands–the chelating agent– to form uncharged chelates. Here, the chelating agent must contain hydrophobic groups and behave as a weak acid, losing a proton to bind with the metal. Since most organic ligands used in this process are insoluble or undergo oxidation in the aqueous phase, the chelating agent is initially added to the organic phase and extracted into the aqueous phase. The metal-ligand complex is...
1.2K


